Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa

ClinicalTrials.gov ID: NCT06212999

Public ClinicalTrials.gov record NCT06212999. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 6:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa

Study identification

NCT ID
NCT06212999
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Incyte Corporation
Industry
Enrollment
617 participants

Conditions and interventions

Interventions

  • Povorcitinib Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 29, 2024
Primary completion
Dec 25, 2026
Completion
Dec 25, 2026
Last update posted
Mar 22, 2026

2024 – 2026

United States locations

U.S. sites
61
U.S. states
24
U.S. cities
54
Facility City State ZIP Site status
Investigative Site US303 Phoenix Arizona 85006
Investigative Site US240 Scottsdale Arizona 85255
Investigative Site US307 Fort Smith Arkansas 72916
Investigative Site US214 Rogers Arkansas 72758
Investigative Site US315 Laguna Niguel California 92677
Investigative Site US223 Los Angeles California 90033
Investigative Site US222 Oakland California 94611
Investigative Site US226 San Diego California 92103
Investigative Site US309 Clearwater Florida 33614
Investigative Site US317 Hialeah Florida 33012-3618
Investigative Site US306 Hollywood Florida 33021
Investigative Site US320 Hollywood Florida 33021
Investigative Site US316 Maitland Florida 32751
Investigative Site US227 Margate Florida 33063
Investigative Site US204 Miami Florida 33125
Investigative Site US236 Miami Florida 33173
Investigative Site US321 North Miami Beach Florida 33162-4708
Investigative Site US200 Ocala Florida 34470
Investigative Site US228 Tampa Florida 33609
Investigative Site US201 Tampa Florida 33613
Investigative Site US311 Marietta Georgia 30060
Investigative Site US220 West Dundee Illinois 60118
Investigative Site US206 Indianapolis Indiana 46250
Investigative Site US337 Indianapolis Indiana 46250
Investigative Site US341 Bowling Green Kentucky 42104
Investigative Site US209 Louisville Kentucky 40241
Investigative Site US305 Baton Rouge Louisiana 70809
Investigative Site US207 Metairie Louisiana 70006
Investigative Site US229 New Orleans Louisiana 70115
Investigative Site US224 Baltimore Maryland 21287
Investigative Site US325 Marriottsville Maryland 21104
Investigative Site US225 Boston Massachusetts 02115
Investigative Site US304 Boston Massachusetts 02215
Investigative Site US310 Brighton Massachusetts 02135
Investigative Site US221 Quincy Massachusetts 02169
Investigative Site US213 Fort Gratiot Michigan 48059
Investigative Site US217 Waterford Michigan 48328
Investigative Site US212 Minneapolis Minnesota 55455
Investigative Site US302 St Louis Missouri 63110
Investigative Site US318 Portsmouth New Hampshire 03801
Investigative Site US230 East Windsor New Jersey 08520
Investigative Site US324 Kew Gardens New York 11415
Investigative Site US202 New York New York 10028
Investigative Site US210 Rochester New York 14620
Investigative Site US205 Chapel Hill North Carolina 27516
Investigative Site US215 Bexley Ohio 43209
Investigative Site US339 Bexley Ohio 43209
Investigative Site US330 Boardman Ohio 44512
Investigative Site US314 Cincinnati Ohio 45219
Investigative Site US312 Cleveland Ohio 44106
Investigative Site US203 Gahanna Ohio 43230
Investigative Site US301 Portland Oregon 97201
Investigative Site US232 Murfreesboro Tennessee 37130
Investigative Site US235 Arlington Texas 76011
Investigative Site US218 Bellaire Texas 77401
Investigative Site US340 Bellaire Texas 77401
Investigative Site US238 Pflugerville Texas 78660
Investigative Site US300 Plano Texas 75025
Investigative Site US234 San Antonio Texas 78213
Investigative Site US313 Norfolk Virginia 23502
Investigative Site US308 Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 104 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06212999, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 22, 2026 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06212999 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →